Home
About
Overview
Sharing Data
ORCID
Help
History (8)
High-Throughput Identification of Causal Variants Underlying Cardiac Arrhythmia-Related GWAS Hits
The case of a 29-year-old woman with headaches and diplopia.
Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine Tumors.
Open-Source Inline Generative AI for Fast Cardiac MRI.
Region-specific expression of two mouse homeo box genes.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Ji, Yuan
One or more keywords matched the following items that are connected to
Ji, Yuan
Item Type
Name
Concept
Dose-Response Relationship, Drug
Academic Article
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
Academic Article
Dose--schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation.
Academic Article
Dose-finding in phase I clinical trials based on toxicity probability intervals.
Academic Article
Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trials.
Academic Article
Risk-group-specific dose finding based on an average toxicity score.
Academic Article
An integrated dose-finding tool for phase I trials in oncology.
Academic Article
A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2.
Academic Article
The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.
Academic Article
R-TPI: rolling toxicity probability interval design to shorten the duration and maintain safety of phase I trials.
Academic Article
The i3+3 design for phase I clinical trials.
Academic Article
Monitoring late-onset toxicities in phase I trials using predicted risks.
Academic Article
[Effect of Sudan I, III and IV on proliferation of HepG-2 and SGC-7901].
Academic Article
A Multi-Arm Two-Stage (MATS) design for proof-of-concept and dose optimization in early-phase oncology trials.
Search Criteria
Dose Response Relationship Drug